STADApharm GmbH
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 6
- Shared contracts
- 6 (multi-supplier framework agreements)
- Period
- 3 July 2026 – 1 October 2026
Its main clients
- DAK-Gesundheit · 5 contracts
- Techniker Krankenkasse · 1 contract
Where and what
Supplies · 6
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 1 December 2026 re-tender around October 2026 |
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoetin (ausschließlich Epoetin zeta), ATC B03XA01 für die Zeit 01.12.2024 - 30.11.2026
DAK-Gesundheit |
Pfizer Pharma GmbH STADApharm GmbH 8 bids received |
€1 |
| 31 December 2028 re-tender around July 2028 |
Ersatzkassen-Generika Nr. 30 (Bekanntmachung vergebener Aufträge)
Techniker Krankenkasse framework agreement |
BG Hexal 1 A Pharma GbR Hexal AG 1 A Pharma GmbH PUREN Pharma GmbH & Co. KG Zentiva Pharma GmbH Micro Labs GmbH BG ALIUD / STADAPHARM GbR Aliud Pharma GmbH STADAPHARM GmbH HIKMA PHARMA GMBH HEC Pharm GmbH Aristo Pharma GmbH Abanta Pharma GmbH Ascend GmbH Holsten Pharma GmbH Devatis GmbH Glenmark Arzneimittel GmbH BG Heumann / Heunet GbR Heumann Pharma GmbH & Co. Generica KG Heunet Pharma GmbH Abdi Farma GmbH Pfizer Pharma GmbH Chiesi GmbH 8 bids received |
€1 |
Contracts won
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.